Home › Funds › Deep Track Capital, LP › BMRN

Deep Track Capital, LP position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Deep Track Capital, LP reported holding 3,307,481 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$189.3M, representing 2.82% of its reported portfolio and ranking #11 among its reported holdings. Deep Track Capital, LP has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)3.31M sh
Reported value held$189.25M
Portfolio Weight2.82%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's BMRN position evolved

Deep Track Capital, LP first disclosed a stake in BMRN in Q3 2025 at 24,856 shares (US$1.3M). The position peaked in Q2 2026 at 3,307,481 shares, worth US$189.3M. Across 4 filings, Deep Track Capital, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,307,481 shares valued at US$189.3M — an increase of 2,157,481 shares quarter over quarter.. Notable position changes include a 9153% increase in Q4 2025 (shares fell 5% over the following quarter), a 50% trim in Q1 2026 (shares rose 1% over the following quarter), a 188% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 24.86K $1.35M New
Q4 2025 2.30M $136.69M Add
Q1 2026 1.15M $64.96M Reduce
Q2 2026 3.31M $189.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Deep Track Capital, LP held BMRN?

Deep Track Capital, LP has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Deep Track Capital, LP's current position in BMRN?

As of Q2 2026, Deep Track Capital, LP holds 3.31M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $189.25M, representing 2.82% of its reported portfolio and ranking #11.

Has Deep Track Capital, LP been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP increased its position in BMRN. The position peaked in Q2 2026 at 3.31M shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.